The Lymphangiomatosis & Gorham's Disease Alliance (LGDA) is a nonprofit organization that promotes and funds research that improves the quality of life of patients with complex lymphatic anomalies (CLAs) including generalized lymphatic anomaly (GLA), kaposiform lymphangiomatosis (KLA), Gorham-Stout disease (GSD) and central conducting lymphatic anomaly (CCLA). The mission of LGDA is to improve the care of patients, identify effective treatments, and ultimately find cures for CLAs through scientific research. The organization aims to achieve this goal by providing opportunities for clinical and basic science research, educating medical professionals to better understand these diseases and increasing public awareness and distributing comprehensive information about CLAs to patients, the medical community, the public, and the media. For more information, visit: https://www.lgdalliance.org
Disclaimer: The information contained in this page is provided by the partnering patient organization for informational purposes only. The 40 Percent Inc. does not warrant its completeness or accuracy, and it should not be construed as an endorsement by The 40 Percent Inc. or relied upon as a basis for your support for the partnering patient organization. The information is subject to change without notice.